Abbott Laboratories (ABT) Debt/Assets Ratio: History & Chart

Abbott Laboratories(ABT)

Medical - Devices · Abbott Park, IL

$105.52+0.00 (+0.00%)

Delayed quote: Sep 8, 2026, 4:02 PM EDT

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

115,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

ABT Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

29.86%

DEBT TO ASSETS RATIO AVG TTM

21.89%

DEBT TO ASSETS RATIO AVG 3Y

19.13%

DEBT TO ASSETS RATIO AVG 5Y

21.57%

DEBT TO ASSETS RATIO AVG 10Y

25.81%

DEBT TO ASSETS RATIO AVG 15Y

24.62%

DEBT TO ASSETS RATIO AVG 20Y

26.37%

CURRENT VS TTM AVG

+36.41%

CURRENT VS 3Y AVG

+56.07%

CURRENT VS 5Y AVG

+38.45%

CURRENT VS 10Y AVG

+15.67%

CURRENT VS 15Y AVG

+21.29%

CURRENT VS 20Y AVG

+13.23%

SECTOR MEDIAN · HEALTHCARE

0.28%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+10563.11%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Abbott Laboratories (ABT)	$182.59B	29.86%	21.89%	19.13%	21.57%
Gilead Sciences, Inc. (GILD)vs ›	$182.06B	0.53%	N/A	N/A	N/A
Novo Nordisk A/S (NVO)vs ›	$200.54B	0.24%	N/A	N/A	N/A
Pfizer Inc. (PFE)vs ›	$158.39B	0.31%	N/A	N/A	N/A
Amgen Inc. (AMGN)vs ›	$212.20B	0.60%	N/A	N/A	N/A
Danaher Corporation (DHR)vs ›	$144.25B	0.29%	N/A	N/A	N/A
Thermo Fisher Scientific Inc. (TMO)vs ›	$224.09B	0.38%	N/A	N/A	N/A
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$134.24B	0.07%	N/A	N/A	N/A
Bristol-Myers Squibb Company (BMY)vs ›	$132.14B	0.49%	N/A	N/A	N/A
Intuitive Surgical, Inc. (ISRG)vs ›	$123.70B	0.00%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Abbott Laboratories (ABT)

$182.59B

29.86%

21.89%

19.13%

21.57%

Gilead Sciences, Inc. (GILD)vs ›

$182.06B

0.53%

N/A

Novo Nordisk A/S (NVO)vs ›

$200.54B

0.24%

N/A

Pfizer Inc. (PFE)vs ›

$158.39B

0.31%

N/A

Amgen Inc. (AMGN)vs ›

$212.20B

0.60%

N/A

Danaher Corporation (DHR)vs ›

$144.25B

0.29%

N/A

Thermo Fisher Scientific Inc. (TMO)vs ›

$224.09B

0.38%

N/A

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$134.24B

0.07%

N/A

Bristol-Myers Squibb Company (BMY)vs ›

$132.14B

0.49%

N/A

Intuitive Surgical, Inc. (ISRG)vs ›

$123.70B

0.00%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Abbott Laboratories (ABT)?

The debt to assets ratio for ABT stock is 29.86%.

Is Abbott Laboratories's debt to assets ratio high or low?

The debt to assets ratio of 29.86% is 38% above its 5-year average of 21.57%, near the high end of its 5-year range (15.37%–30.83%).

What is the TTM average debt to assets ratio for Abbott Laboratories (ABT)?

The TTM average debt to assets ratio for ABT stock is 21.89%.

What is the 3Y average debt to assets ratio for Abbott Laboratories (ABT)?

The 3Y average debt to assets ratio for ABT stock is 19.13%.

What is the 5Y average debt to assets ratio for Abbott Laboratories (ABT)?

The 5Y average debt to assets ratio for ABT stock is 21.57%.

What is the 10Y average debt to assets ratio for Abbott Laboratories (ABT)?

The 10Y average debt to assets ratio for ABT stock is 25.81%.

What is the 15Y average debt to assets ratio for Abbott Laboratories (ABT)?

The 15Y average debt to assets ratio for ABT stock is 24.62%.

What is the 20Y average debt to assets ratio for Abbott Laboratories (ABT)?

The 20Y average debt to assets ratio for ABT stock is 26.37%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	29.86%
2026-03-31	30.83%
2025-12-31	17.38%
2025-09-30	15.37%
2025-06-30	16.00%
2025-03-31	16.26%
2024-12-31	18.76%
2024-09-30	20.14%
2024-06-30	20.21%
2024-03-31	20.13%
2023-12-31	21.68%
2023-09-30	21.54%
2023-06-30	22.97%
2023-03-31	22.90%
2022-12-31	24.11%
2022-09-30	22.55%
2022-06-30	22.59%
2022-03-31	23.09%
2021-12-31	25.60%
2021-09-30	24.93%
2021-06-30	25.25%
2021-03-31	25.34%
2020-12-31	27.42%
2020-09-30	26.89%
2020-06-30	28.61%
2020-03-31	27.36%
2019-12-31	28.13%
2019-09-30	29.18%
2019-06-30	29.33%
2019-03-31	29.44%
2018-12-31	29.13%
2018-09-30	32.89%
2018-06-30	30.21%
2018-03-31	30.87%
2017-12-31	36.62%
2017-09-30	33.25%
2017-06-30	33.77%
2017-03-31	33.82%
2016-12-31	40.00%
2016-09-30	21.55%
2016-06-30	22.37%
2016-03-31	21.67%
2015-12-31	21.82%
2015-09-30	20.02%
2015-06-30	19.85%
2015-03-31	20.66%
2014-12-31	19.01%
2014-09-30	19.53%
2014-06-30	17.76%
2014-03-31	18.64%
2013-12-31	15.27%
2013-09-30	18.72%
2013-06-30	18.49%
2013-03-31	16.64%
2012-12-31	30.45%
2012-09-30	25.74%
2012-06-30	29.24%
2012-03-31	26.67%
2011-12-31	25.57%
2011-09-30	28.04%
2011-06-30	29.38%
2011-03-31	30.47%
2010-12-31	31.82%
2010-09-30	32.62%
2010-06-30	34.62%
2010-03-31	32.47%
2009-12-31	31.39%
2009-09-30	31.40%
2009-06-30	32.97%
2009-03-31	34.58%
2008-12-31	26.98%
2008-09-30	27.21%
2008-06-30	31.51%
2008-03-31	32.11%
2007-12-31	30.75%
2007-09-30	32.54%
2007-06-30	33.18%
2007-03-31	34.38%
2006-12-31	34.31%
2006-09-30	28.36%
2006-06-30	30.61%
2006-03-31	22.05%
2005-12-31	22.76%
2005-09-30	22.83%
2005-06-30	20.62%
2005-03-31	24.87%
2004-12-31	23.57%
2004-09-30	23.88%
2004-06-30	25.16%
2004-03-31	23.83%
2003-12-31	22.42%
2003-09-30	25.34%
2003-06-30	23.73%
2003-03-31	26.00%
2002-12-31	26.48%
2002-09-30	29.32%

DATE

DEBT TO ASSETS RATIO

2026-06-30

29.86%

2026-03-31

30.83%

2025-12-31

17.38%

2025-09-30

15.37%

2025-06-30

16.00%

2025-03-31

16.26%

2024-12-31

18.76%

2024-09-30

20.14%

2024-06-30

20.21%

2024-03-31

20.13%

2023-12-31

21.68%

2023-09-30

21.54%

2023-06-30

22.97%

2023-03-31

22.90%

2022-12-31

24.11%

2022-09-30

22.55%

2022-06-30

22.59%

2022-03-31

23.09%

2021-12-31

25.60%

2021-09-30

24.93%

2021-06-30

25.25%

2021-03-31

25.34%

2020-12-31

27.42%

2020-09-30

26.89%

2020-06-30

28.61%

2020-03-31

27.36%

2019-12-31

28.13%

2019-09-30

29.18%

2019-06-30

29.33%

2019-03-31

29.44%

2018-12-31

29.13%

2018-09-30

32.89%

2018-06-30

30.21%

2018-03-31

30.87%

2017-12-31

36.62%

2017-09-30

33.25%

2017-06-30

33.77%

2017-03-31

33.82%

2016-12-31

40.00%

2016-09-30

21.55%

2016-06-30

22.37%

2016-03-31

21.67%

2015-12-31

21.82%

2015-09-30

20.02%

2015-06-30

19.85%

2015-03-31

20.66%

2014-12-31

19.01%

2014-09-30

19.53%

2014-06-30

17.76%

2014-03-31

18.64%

2013-12-31

15.27%

2013-09-30

18.72%

2013-06-30

18.49%

2013-03-31

16.64%

2012-12-31

30.45%

2012-09-30

25.74%

2012-06-30

29.24%

2012-03-31

26.67%

2011-12-31

25.57%

2011-09-30

28.04%

2011-06-30

29.38%

2011-03-31

30.47%

2010-12-31

31.82%

2010-09-30

32.62%

2010-06-30

34.62%

2010-03-31

32.47%

2009-12-31

31.39%

2009-09-30

31.40%

2009-06-30

32.97%

2009-03-31

34.58%

2008-12-31

26.98%

2008-09-30

27.21%

2008-06-30

31.51%

2008-03-31

32.11%

2007-12-31

30.75%

2007-09-30

32.54%

2007-06-30

33.18%

2007-03-31

34.38%

2006-12-31

34.31%

2006-09-30

28.36%

2006-06-30

30.61%

2006-03-31

22.05%

2005-12-31

22.76%

2005-09-30

22.83%

2005-06-30

20.62%

2005-03-31

24.87%

2004-12-31

23.57%

2004-09-30

23.88%

2004-06-30

25.16%

2004-03-31

23.83%

2003-12-31

22.42%

2003-09-30

25.34%

2003-06-30

23.73%

2003-03-31

26.00%

2002-12-31

26.48%

2002-09-30

29.32%

Debt to Assets Ratio: 29.86%

ABT Debt to Assets Ratio

ABT Average Debt to Assets Ratio Chart

ABT Current vs Average Debt to Assets Ratio Chart

ABT Debt to Assets Ratio Metrics

ABT Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

ABT Debt to Assets Ratio History

Related Metrics